(Q40657593)

English

ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells

scientific article published on April 2003

Statements

ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells (English)
Pablo Matar
Marta Guzmán
Federico Rojo
Joaquin Arribas
1 April 2003
1274-1283

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit